You can also view this study directly in Truveta Studio
Obesity is a multi-systemic disease state with several associated complications such as musculoskeletal issues, obstructive sleep apnoea, cardiovascular disease, infertility, and cancer (endometrial, breast, ovarian, prostate, liver, gallbladder, kidney, and colon) as well as significant metabolic sequelae, the most important being type 2 diabetes due to its high morbidity and mortality through micro- and macro-vascular complications such as ischaemic heart disease, stroke, and peripheral vascular disease [3, 4]
As of January 2026, only 13 states provided Medicaid coverage for GLP-1 medications for obesity treatment down from 16 states in 2025, largely due to budget pressure from federal funding changes
Allow vial to equilibrate before opening to prevent condensation
It's crucial to inform your healthcare provider of any personal or family history of thyroid cancer or other endocrine disorders
A friend of mine in Edmonton had started using research peptides and told me about a Canadian supplier that shipped from BC